Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2021 Jan 5;30(3):105586. doi: 10.1016/j.jstrokecerebrovasdis.2020.105586

Table 3.

Acute stroke in-hospital process of care metrics stratified by race/ethnicity in relation to mortality and 30-day readmission in the FSR. These results were generated from multi-level logistic regression models to account for clustering within hospitals.

Acute Care Metrics 30-day mortality OR (95% CI)* 6-month mortality OR (95% CI)* 30-day readmissions OR (95% CI)*
rt-PA, arrive by 2 hrs and treat by 3 hrs
White 0.92 (0.43–1.99) 0.92 (0.44–1.91) 0.83 (0.45–1.55)
Black 0.25 (0.05–1.20)
Hispanic 0.93 (0.07–12.63) 1.64 (0.19–13.95)

Early Antithrombotic Use
White 0.48 (0.34–0.67) 0.55 (0.44–0.70) 0.93 (0.72–1.21)
Black 0.98 (0.40–2.42) 0.70 (0.42–1.15) 0.60 (0.34–1.05)
Hispanic 0.79 (0.49–1.26) 0.87 (0.61–1.24) 0.97 (0.55–1.73)

Antithrombotics at Discharge
White 0.38 (0.23–0.61) 0.61 (0.40–0.91) 1.03 (0.77–1.36)
Black 0.90 (0.46–1.78) 0.57 (0.34–0.93) 0.87 (0.45–1.65)
Hispanic 0.24 (0.10–0.59) 0.44 (0.18–1.09) 1.01 (0.54–1.89)

Anticoagulation for Atrial Fibrillation
White 0.58 (0.29–1.18) 0.83 (0.50–1.37) 0.93 (0.57–1.51)
Black 0.35 (0.06–2.09) 0.45 (0.13–1.53) 0.90 (0.08–9.57)
Hispanic 1.31 (0.53–5.33) 0.96 (0.48–1.92) 3.40 (0.68–17.09)

Smoking Cessation Counseling
White 1.77 (0.44–7.16) 2.09 (0.68–6.42)
Black 0.67 (0.17–2.68) 0.29 (0.03–2.44)
Hispanic 0.65 (0.04–10.30) 0.32 (0.07–1.46)

LDL 100 or ND – Statin
White 0.60 (0.39–0.92) 0.68 (0.51–0.90) 0.92 (0.75–1.12)
Black 2.36 (0.74–7.55) 0.86 (0.53–1.37) 0.65 (0.42–0.99)
Hispanic 0.94 (0.58–1.52) 1.12 (0.77–1.61) 0.74 (0.46–1.20)

VTE prophylaxis
White 0.96 (0.72–1.29) 0.90 (0.72–1.12) 1.01 (0.83–1.24)
Black 1.18 (0.63–2.19) 1.04 (0.68–1.59) 0.93 (0.64–1.35)
Hispanic 1.00 (0.70–1.43) 1.07 (0.84–1.36) 1.31 (0.84–2.04)
*

Controlling for age, sex, and NIHSS (where results are missing the models did not converge)